SEC Tracker
Get the app

Roivant Sciences ROIV

Mayukh Sukhatme (President & CIO) withheld for taxes 19,976 ROIV at $33.53, worth $670K

Form
4
Filed
Importance
Routine
  1. 19,976 shares disposed of on Oct 16, 2026
  2. 18,563,884 shares owned
  3. Common shares held directly
  4. Settlement of performance restricted stock units (shares paid out if performance goals are met)

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Roivant Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Neurocrine Biosciences NBIX public float $9.5B, Jun 30, 2025
  2. Exelixis EXEL public float $9.4B, Jul 4, 2025
  3. BIO-TECHNE TECH public float $9.1B, Dec 31, 2025
  4. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  5. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.